Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS4 – Molecularly stratified therapy in advanced colorectal cancer
2012-005111-12Phase 2Unknown
- Sponsor
- University College London
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sapitinib in metastatic colorectal adenocarcinoma (mCRC), colorectal cancer (CRC), sponsored by University College London. Status: unknown.
02
Drugs
sapitinib
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)colorectal cancer (CRC)
Beyond the preview
Go deeper on 2012-005111-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005111-12.